Clinical Trials in Colorado

Showing 961-980 of 15,592 trials

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

NCT06660290

The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).

Dry Eye Disease

Alcon Research55 participantsStarted Jan 2025

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Andover, Massachusetts, United States +3 more locations

RECRUITINGPhase 246 miles

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NCT07082738

This Phase IIb dose-ranging study will evaluate the efficacy and safety of 3 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

Chronic Obstructive Pulmonary Disease (COPD)

AstraZeneca1,160 participantsStarted Jun 2025

Birmingham, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +360 more locations

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Find Trials by Condition in Colorado

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Evolut™ EXPAND TAVR II Pivotal Trial

Improving Medical Decision Making for Older Patients With End Stage Renal Disease

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Mucopolysaccharidosis VII Disease Monitoring Program

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Actinium Therapy for Late-stage Aggressive Sarcomas

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Empathic Communication Skills (ECS) Training

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Donidalorsen Treatment in Children With Hereditary Angioedema